CATHEDRA BITCOIN INC
CBTTF
The9 Ltd
NCTY
Bit Origin
BTOG
Intchains Group
ICG
SATO TECHNOLOGIES CORP
CCPUF
US Stock MarketDetailed Quotes
VVOS Vivos Therapeutics
- 4.8022
- -0.1478-2.99%
Trading Dec 17 11:01 ET
23.22MMarket Cap-0.96P/E (TTM)
5.1700High4.7450Low64.19KVolume5.0500Open4.9500Pre Close316.49KTurnover1.45%Turnover RatioLossP/E (Static)4.84MShares12.830852wk High3.03P/B21.27MFloat Cap1.910052wk Low--Dividend TTM4.43MShs Float360.2500Historical High--Div YieldTTM8.59%Amplitude1.9100Historical Low4.9300Avg Price1Lot Size
Vivos Therapeutics Key Stats
EPS
According to the latest financial report of Vivos Therapeutics, the latest earnings per share (TTM) for the company is -0.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Vivos Therapeutics's free cash flow? The latest report shows it as -4.38M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vivos Therapeutics shows that the company's current ratio is 1.44, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vivos Therapeutics, the quick ratio is 1.32, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Vivos Therapeutics? The latest ROE figure is -37.34%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vivos Therapeutics, the total asset return on investment (ROA) is -16.78%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vivos Therapeutics's latest financial report to see how their gross margin is doing - currently at 60.47%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vivos Therapeutics, the net profit margin is -67.77%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.